Ziyue Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ziyue Li has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Changchun Liu
Department of Biomedical Engineering University of Connecticut Health Center Farmington Connecticut USA
2 shared publications - Holly McGinnis
Connecticut Veterinary Medical Diagnostic Laboratory, Department of Pathobiology and Veterinary Science, College of Agriculture, Health and Natural Resources, University of Connecticut, Storrs, CT 06269, USA
1 shared publication - Joan A. Smyth
Department of Pathobiology and Veterinary Science, University of Connecticut, Storrs, CT, USA
1 shared publication - Kun Yin
Department of Biomedical Engineering, University of Connecticut Health Center, Farmington, CT 06030, USA
1 shared publication - Kun Yin
Department of Mechanical Engineering and Applied Mechanics, University of Pennsylvania, 220 South 33rd St. Philadelphia, PA 19104-6315, USA
1 shared publication - Maureen Sims
Connecticut Veterinary Medical Diagnostic Laboratory, Department of Pathobiology and Veterinary Science, College of Agriculture, Health and Natural Resources, University of Connecticut, Storrs, CT 06269, USA
1 shared publication
Latest Publications
- Open Access
- 10 August 2021
- Published by MDPI AG in Applied Sciences
- Vol. 11 (16) , 7355
TickPhone App: A Smartphone Application for Rapid Tick Identification Using Deep Learning
Tick species are considered the second leading vector of human diseases. Different ticks can transmit a variety of pathogens that cause various tick-borne diseases (TBD), such as Lyme disease. Currently, it remains a challenge to diagnose Lyme disease because of its non-specific symptoms. Rapid and accurate identification of tick species plays an important role in predicting potential disease risk for tick-bitten patients, and ensuring timely and effective treatment. Here, we developed, optimized, and tested a smartphone-based deep learning algorithm (termed “TickPhone app”) for tick identification. The deep learning model was trained by more than 2000 tick images and optimized by different parameters, including normal sizes of images, deep learning architectures, image styles, and training–testing dataset distributions. The optimized deep learning model achieved a training accuracy of ~90% and a validation accuracy of ~85%. The TickPhone app was used to identify 31 independent tick species and achieved an accuracy of 95.69%. Such a simple and easy-to-use TickPhone app showed great potential to estimate epidemiology and risk of tick-borne disease, help health care providers better predict potential disease risk for tick-bitten patients, and ultimately enable timely and effective medical treatment for patients.
- 10 August 2021
- Published by MDPI AG in Applied Sciences
- Vol. 11 (16) , 7355
Open AccessTickPhone App: A Smartphone Application for Rapid Tick Identification Using Deep Learning
Tick species are considered the second leading vector of human diseases. Different ticks can transmit a variety of pathogens that cause various tick-borne diseases (TBD), such as Lyme disease. Currently, it remains a challenge to diagnose Lyme disease because of its non-specific symptoms. Rapid and accurate identification of tick species plays an important role in predicting potential disease risk for tick-bitten patients, and ensuring timely and effective treatment. Here, we developed, optimized, and tested a smartphone-based deep learning algorithm (termed “TickPhone app”) for tick identification. The deep learning model was trained by more than 2000 tick images and optimized by different parameters, including normal sizes of images, deep learning architectures, image styles, and training–testing dataset distributions. The optimized deep learning model achieved a training accuracy of ~90% and a validation accuracy of ~85%. The TickPhone app was used to identify 31 independent tick species and achieved an accuracy of 95.69%. Such a simple and easy-to-use TickPhone app showed great potential to estimate epidemiology and risk of tick-borne disease, help health care providers better predict potential disease risk for tick-bitten patients, and ultimately enable timely and effective medical treatment for patients.
- Open Access
All-in-One Dual CRISPR-Cas12a (AIOD-CRISPR) Assay: A Case for Rapid, Ultrasensitive and Visual Detection of Novel Coronavirus SARS-CoV-2 and HIV virus
A recent outbreak of novel coronavirus (SARS-CoV-2), the causative agent of COVID-19, has spread rapidly all over the world. Human immunodeficiency virus (HIV) is another deadly virus and causes acquired immunodeficiency syndrome (AIDS). Rapid and early detection of these viruses will facilitate early intervention and reduce disease transmission risk. Here, we present an A ll- I n- O ne D ual CRISPR -Cas12a (termed “AIOD-CRISPR”) assay method for simple, rapid, ultrasensitive, one-pot, and visual detection of coronavirus SARS-CoV-2 and HIV virus. In our AIOD CRISPR assay, a pair of crRNAs was introduced to initiate dual CRISPR-Cas12a detection and improve detection sensitivity. The AIOD-CRISPR assay system was successfully utilized to detect nucleic acids (DNA and RNA) of SARS-CoV-2 and HIV with a sensitivity of few copies. Also, it was evaluated by detecting HIV-1 RNA extracted from human plasma samples, achieving a comparable sensitivity with real-time RT-PCR method. Thus, our method has a great potential for developing next-generation point-of-care molecular diagnostics.
Open AccessAll-in-One Dual CRISPR-Cas12a (AIOD-CRISPR) Assay: A Case for Rapid, Ultrasensitive and Visual Detection of Novel Coronavirus SARS-CoV-2 and HIV virus
A recent outbreak of novel coronavirus (SARS-CoV-2), the causative agent of COVID-19, has spread rapidly all over the world. Human immunodeficiency virus (HIV) is another deadly virus and causes acquired immunodeficiency syndrome (AIDS). Rapid and early detection of these viruses will facilitate early intervention and reduce disease transmission risk. Here, we present an A ll- I n- O ne D ual CRISPR -Cas12a (termed “AIOD-CRISPR”) assay method for simple, rapid, ultrasensitive, one-pot, and visual detection of coronavirus SARS-CoV-2 and HIV virus. In our AIOD CRISPR assay, a pair of crRNAs was introduced to initiate dual CRISPR-Cas12a detection and improve detection sensitivity. The AIOD-CRISPR assay system was successfully utilized to detect nucleic acids (DNA and RNA) of SARS-CoV-2 and HIV with a sensitivity of few copies. Also, it was evaluated by detecting HIV-1 RNA extracted from human plasma samples, achieving a comparable sensitivity with real-time RT-PCR method. Thus, our method has a great potential for developing next-generation point-of-care molecular diagnostics.